What is China's new commercial insurance drug list?

China introduced a commercial insurance innovative drug list on January 1, adding 114 new drugs to enhance healthcare coverage, especially for cancer and rare diseases.

How does China's new drug list help patients?

The new list aims to reduce financial burdens on patients by including high-cost innovative drugs for advanced treatments and recommending them for commercial insurer coverage.

Which types of drugs are included in China's updated list?

The updated list includes advanced drugs such as new Alzheimer's medications and treatments for rare diseases like Gaucher, as well as CAR T-cell therapy for cancer.

Home / Health / China Expands Health Coverage for Cancer Drugs

China Expands Health Coverage for Cancer Drugs

12 Feb

•

Summary

China added 114 new drugs to its commercial insurance list.
The update covers high-cost innovative drugs for cancer and rare diseases.
This aims to reduce patient financial burdens on advanced treatments.

China Expands Health Coverage for Cancer Drugs

As of January 1, China introduced a commercial insurance innovative drug list, significantly enhancing healthcare coverage. This initiative aims to alleviate the financial pressure on individuals requiring advanced medical treatments, especially for cancer and rare diseases. The expanded list incorporates 114 new drugs, with 19 specific high-cost innovative medications now recommended for commercial insurer coverage.

These newly added drugs must address unmet clinical needs, offer superior alternatives to existing treatments, or demonstrate better cost-effectiveness. This policy strengthens China's multi-tiered healthcare safety net, with basic insurance covering essential care and commercial plans addressing gaps for more expensive therapies.